Aliases for APOC1 Gene
External Ids for APOC1 Gene
Previous GeneCards Identifiers for APOC1 Gene
This gene encodes a member of the apolipoprotein C1 family. This gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. The encoded protein plays a central role in high density lipoprotein (HDL) and very low density lipoprotein (VLDL) metabolism. This protein has also been shown to inhibit cholesteryl ester transfer protein in plasma. A pseudogene of this gene is located 4 kb downstream in the same orientation, on the same chromosome. This gene is mapped to chromosome 19, where it resides within a apolipoprotein gene cluster. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Sep 2016]
GeneCards Summary for APOC1 Gene
APOC1 (Apolipoprotein C1) is a Protein Coding gene. Diseases associated with APOC1 include Adermatoglyphia and Alzheimer Disease. Among its related pathways are Statin Pathway and Metabolism. Gene Ontology (GO) annotations related to this gene include phosphatidylcholine binding and phospholipase inhibitor activity.
UniProtKB/Swiss-Prot Summary for APOC1 Gene
Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10% of the protein of the VLDL and 2% of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.